Epitome Medical is a company that specializes in providing innovative medical devices and solutions designed to improve patient outcomes. Their product offerings focus on areas such as pain management, physical therapy, and orthopedic rehabilitation.

Epitome Medical

Epitomee is a medical devices company developing ingestible devices to tackle some of today’s most prevalent chronic diseases at their core with a self-managed, safe and effective way. Epitomee  has developed,  and is commercializing drug-free self-administered capsules, aimed to prevent diabetes and address overweight & obesity comorbidities by promoting weight loss and establishing a healthier lifestyle.

GCB Services

XT Hi-Tech

Shimon Eckhouse

Epitomee Medical

We're excited to announce the submission of our groundbreaking Weight Loss Capsule for FDA clearance! This is a significant step towards commercializing our innovative solution in the US. We look forward to bringing this advancement to healthcare professionals & consumers, signaling a new chapter in weight management.
For more details, read the full release here: https://lnkd.in/d7GK7_Xr
Link to our website: https://lnkd.in/dFkNVr8r

Donna Ryan Shimon Eckhouse Dan Hashimshony
#thenewwaytomanageweight #Epitomee #qualityoflife #WeightManagement #FDA

Update from Epitomee - Our research, published in Obesity Pillars, offers new insights into the role of the Epitomee® Capsule in weight management.
 
Led by Haim Shirin, this further analysis demonstrates significant improvements in weight reduction and cardiovascular risk factors, alongside enhancements in PROs such as improved early satiety, decreased snacking, and reduced meal size with the Epitomee® Capsule.
Read the full study here: https://lnkd.in/dXWNHUgu
 
Donna Ryan Dan Hashimshony Shimon Eckhouse
 
#EpitomeeMedical #WeightManagement #thenewwaytomanageweight #ObesityPillars

Following our recent update about completing the RESET trial on Epitomee® weight loss capsule, please note that the abstract- Baseline Characteristics of Participants in RESET, presented by Dr. Jamy Ard at Obesity Week, was published in the The Obesity Society Journal.
Baseline characteristics of RESET participants broadly represent individuals with overweight or obesity, seeking weight loss treatment and confirms that appropriate population was recruited, allowing adequate investigation of the safety & effectiveness of Epitomee® for weight-reduction.

Read the abstract on our site: https://lnkd.in/d-5hqGw9
 
Special thanks to Jamy Ard and Donna Ryan for their contributions.
 
Dan Hashimshony Shimon Eckhouse
 
#WeightLossInnovation #ObesityWeek #RESETTrial #ObesityJournal #thenewwaytomanageweight

We are proud to announce successful completion of the landmark pivotal clinical trial, RESET, for Epitomee®'s innovative weight loss capsule. RESET confirmed the effectiveness & safety of Epitomee® capsules in addressing overweight & obesity challenges. Beyond weight loss, Epitomee® has proven to enhance quality of life. 
A major milestone in health and wellness!

Read more about in the following links:
link to press release: https://lnkd.in/d2arUFun
link to website: https://lnkd.in/d_2evn_h

#thenewwaytomanageweight #Epitomee #RESETtrial #healthinnovation  #qualityoflife 

Coming up tomorrow! The Baseline Characteristics of Participants in Epitomee® RESET study, presented by Prof. Jamy Ard. The pivotal study on our novel biodegradable device for weight loss
10/16/2023, 10:15 am at Kay Bailey Hutchison Convention Center-D174, Dallas
#Thenewwaytomanageweight

Join upcoming ObesityWeek®2023! Learn about Epitomee® pivotal study on our novel biodegradable device for weight loss- The Baseline Characteristics of Participants in Epitomee® RESET, will be presented by Prof. Jamy Ard, esteemed Professor of Epidemiology and Prevention and Vice) Dean for Clinical Research at the Wake Forest School of Medicine. 

10/16/2023, 10:15 am at Kay Bailey Hutchison Convention Center-D174, Dallas.
https://obesityweek.org/
#Thenewwaytomanageweight

Metric
Company Name	Epitome Medical
Symbol
MSH ID	COM:EPITOMEEMEDICAL
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Devices
Country	IL
Stage
Employee Count	32
Website	epitomeemedical.com
LinkedIn	epitomeemedical
Founders

Metric
Market Cap	270.19M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	40.70
28-Day Growth Score	52.50
90-Day Growth Score	55.26
365-Day Growth Score	50.44

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:EPITOMEEMEDICAL

Epitome Medical

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue